What are the potential interactions between montelukast (Singulair) and cetirizine (Zyrtec)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Montelukast and Cetirizine Interactions

Direct Answer

There are no clinically significant drug-drug interactions between montelukast and cetirizine, and these medications can be safely used together. In fact, combining these agents may provide additive therapeutic benefit for allergic conditions compared to either medication alone 1, 2.

Safety Profile of Combination Therapy

No Pharmacokinetic Interactions

  • Montelukast is alkaline-stable while cetirizine (levocetirizine dihydrochloride) is acid-stable, which means they have different chemical properties but do not interfere with each other's absorption or metabolism when taken together 3.
  • Both medications have been extensively studied in combination without reports of adverse drug-drug interactions 4, 1, 5.

Clinical Evidence Supporting Combined Use

  • The combination of montelukast with cetirizine has demonstrated greater efficacy than either agent used alone in treating allergic rhinitis, with some studies showing results comparable to intranasal corticosteroids 1.
  • A randomized controlled trial directly comparing montelukast 10 mg once daily with cetirizine 10 mg once daily in chronic urticaria patients found both medications to be safe and effective, with no interaction concerns noted 4.
  • Meta-analysis data confirms that combined therapy with montelukast and antihistamines (including cetirizine) is more effective in improving daytime nasal symptoms than montelukast alone 2.

Important Considerations When Using Both Medications

Sedation Risk

  • Cetirizine may cause mild drowsiness in 13.7% of patients compared to 6.3% with placebo, even at the standard 10 mg dose 6, 7, 8.
  • This sedation risk is not increased by adding montelukast, as montelukast has an excellent safety profile and does not cause sedation 6, 1.
  • If sedation becomes problematic, consider timing cetirizine at bedtime while continuing montelukast in the morning 8.

Renal Impairment Adjustments

  • In patients with moderate renal impairment (creatinine clearance 10-20 mL/min), reduce the cetirizine dose by 50% 6, 7, 9.
  • Cetirizine should be avoided in severe renal impairment (creatinine clearance <10 mL/min) 6, 7.
  • Montelukast does not require renal dose adjustment and can be continued at standard dosing 1.

Neuropsychiatric Considerations

  • Various neuropsychiatric events have been reported with montelukast (leukotriene receptor antagonists), though the evidence of association is conflicting 6.
  • Monitor patients for mood changes, depression, or behavioral changes when initiating montelukast, regardless of whether it's used alone or with cetirizine 6.

Clinical Algorithm for Combined Use

When to Use Combination Therapy

  1. Start with monotherapy using either cetirizine or montelukast as first-line treatment for allergic rhinitis or urticaria 6.
  2. Add the second agent if inadequate response after 2-4 weeks of monotherapy at standard doses 7, 1.
  3. Consider combination therapy upfront in patients with both allergic rhinitis and asthma, as montelukast treats both conditions simultaneously 6, 1.

Dosing Recommendations

  • Cetirizine: 10 mg once daily (may be taken morning or evening) 6, 7.
  • Montelukast: 10 mg once daily (typically taken in the evening) 4, 1, 5.
  • Both medications can be taken at the same time or at different times of day without affecting efficacy or safety 1, 3.

Common Pitfalls to Avoid

Don't Assume Complete Non-Sedation

  • Cetirizine is NOT completely non-sedating like fexofenadine or loratadine at recommended doses 6, 8.
  • Counsel patients about the 13.7% risk of mild drowsiness, especially if they drive or operate machinery 7, 8.

Don't Overlook Renal Function

  • Always check renal function before prescribing cetirizine, as dose adjustment is required in moderate renal impairment 6, 7, 9.
  • Montelukast remains safe at standard doses regardless of renal function 1.

Don't Expect Immediate Synergy in All Conditions

  • While combination therapy is more effective than monotherapy for allergic rhinitis, the addition of montelukast to antihistamines in chronic rhinosinusitis with nasal polyps has not shown consistent benefit 6.
  • The combination is most beneficial for allergic rhinitis, chronic urticaria with food additive/aspirin sensitivity, and patients with concomitant asthma 4, 1, 5.

Don't Use Excessive Doses

  • Avoid taking more than one 10 mg dose of cetirizine in 24 hours, as higher doses increase sedation risk without necessarily improving efficacy 8.
  • Standard dosing of both medications (10 mg each once daily) is sufficient for combination therapy 4, 1, 5.

References

Research

FDC of montelukast with levocetirizine: focus on bilayer technology.

Journal of the Indian Medical Association, 2009

Research

Efficacy of montelukast for treating perennial allergic rhinitis.

Allergy and asthma proceedings, 2007

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Long-Term Cetirizine Use Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cetirizine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cetirizine Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.